Dupilumab eliminated airway hyperresponsiveness in a 12-year-old boy
with severe atopic asthma.
- Kazuyo Kuzume
, - Yu Kuwabara,
- Kiriko Tokuda,
- Kenji Matsumoto
Kazuyo Kuzume
Ehime University Graduate School of Medicine
Corresponding Author:kuzumekazuyo@ybb.ne.jp
Author ProfileKenji Matsumoto
National Research Institute for Child Health and Development
Author Profile
